You are here : Home / All Sectors / Miscellaneous / Miscellaneous / SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Intrinsic Value | Fundamental Analysis

Returns | 1W : 2.1% , 1M : -2%,1Y : 18.9%
BOM : 532872     NSE : SPARC    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Apr 19,2021
Price(EOD): Rs. 159.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 4,184.14 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
SUN PHARMA ADVANCED RESEARCH COMPANY 2.1% -2% 18.9%
SYNGENE INTERNATIONAL 8.4% 12% 110.4%
QUESS CORP -8.6% -20.2% 184.4%
SECURITY AND INTELLIGENCE SERVICES INDIA -1.3% -11.7% -5.2%
TEAMLEASE SERVICES -8.5% -10.7% 105%
DELTA CORP -5.6% -23.2% 118.7%
JUST DIAL 0.9% -3.9% 160.1%
HEALTHCARE GLOBAL ENTERPRISES -0.3% -5.9% 145.7%
FERMENTA BIOTECH 17.2% 6.1% 8.3%

FUNDAMENTAL ANALYSIS OF SUN PHARMA ADVANCED RESEARCH COMPANY

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than SUN PHARMA ADVANCED RESEARCH COMPANY Premium


VALUATION OF SUN PHARMA ADVANCED RESEARCH COMPANY

 
Valuation Score
RatioValue
P/E
P/B
P/S
-
P/E Calculated based on EPS of -11.92
[ Mar2020 - Standalone Results ]

-
P/B Calculated based on Book Value of -0.71
[ Mar2020 - Standalone Results ]

17.08
P/S Calculated based on Revenues of 244.95 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than SUN PHARMA ADVANCED RESEARCH COMPANY Premium


FAIR VALUE OF SUN PHARMA ADVANCED RESEARCH COMPANY

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
-59%
-60%

SHARE PRICE MOMENTUM OF SUN PHARMA ADVANCED RESEARCH COMPANY

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
-3.67
0.01
0.02
-1.21
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
1.9 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
23.64%
-22.87%
-19.01%
-19.01%
11.28%
15.77%
21.82%
21.82%
QtrlyTrend
2
Latest Qtr: Dec2020

SUN PHARMA ADVANCED RESEARCH COMPANY related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 2.5% 9.5% 53.4%
S&P BSE 400 MIDSMALLCAP 0.6% -3.4% 88.9%
S&P BSE MIDSMALLCAP 0.6% -2.9% 87.1%
S&P BSE SMALL CAP 0.6% -2.3% 99.4%
S&P BSE ALLCAP 0.5% -3.5% 67.3%
S&P BSE 500 0.5% -3.5% 66.4%
S&P BSE 250 SMALLCAP -0.2% -4.9% 97.8%
NSE Indices1W1M1Y
NIFTY 500 0.4% -3.5% 65.9%
NIFTY MID SMALL400 0.4% -3.6% 89.2%
NIFTY SMALLCAP250 0.2% -4.1% 100.5%
NIFTY SMALLCAP 50 -0% -5.2% 118.1%
NIFTY FREE SMALL 100 -0.2% -4.5% 108.8%

FAQ [Frequently Asked Questions]


Is SPARC good for long term investment?

As on 19-Apr-2021, the Fundamentals of SPARC are Poor and hence it's not good for long term investment ! See Financial Performance of SUN PHARMA ADVANCED RESEARCH COMPANY . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SPARC UnderValued or OverValued?

As on 19-Apr-2021, SPARC is Under Valued and hence a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SPARC ?

As on 19-Apr-2021, the Intrinsic Value of SPARC is Rs. 392.89 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -3,004.91
Fair Value [Median EV / Sales Model] : Rs. 390.67
Fair Value [Median Price / Sales Model] : Rs. 395.10
Median Fair Value of SPARC : Rs. 392.89

Is SPARC trading at a Premium or Discount?

As on 19-Apr-2021, SPARC is trading at a Discount of -59% based on the Median Intrinsic Value!

Is it right time to buy SPARC shares?

As on 19-Apr-2021, SPARC is Under Valued and hence a good buying opportunity according to Share Valuation at this time!
One can wait for the Share Price Momentum to become bullish before entering the stock!

What is the Financial Performance of Industry Peers of SPARC?

Check out Financials of Industry Peers using below links:
Financials of SYNGENE INTERNATIONAL LTD
Financials of QUESS CORP LTD
Financials of SECURITY AND INTELLIGENCE SERVICES INDIA LTD
Financials of TEAMLEASE SERVICES LTD
Financials of DELTA CORP LTD
Financials of JUST DIAL LTD
Financials of HEALTHCARE GLOBAL ENTERPRISES LTD
Financials of FERMENTA BIOTECH LTD
Financials of VA TECH WABAG LTD
Financials of SAFARI INDUSTRIES (INDIA) LTD

What are the Frequent Comparisons with SPARC?

SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs SYNGENE INTERNATIONAL LTD vs QUESS CORP LTD
SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs SYNGENE INTERNATIONAL LTD vs SECURITY AND INTELLIGENCE SERVICES INDIA LTD
SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs SYNGENE INTERNATIONAL LTD vs TEAMLEASE SERVICES LTD
SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs SYNGENE INTERNATIONAL LTD vs DELTA CORP LTD
SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs SYNGENE INTERNATIONAL LTD vs JUST DIAL LTD
SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs SYNGENE INTERNATIONAL LTD vs HEALTHCARE GLOBAL ENTERPRISES LTD
SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs SYNGENE INTERNATIONAL LTD vs FERMENTA BIOTECH LTD
SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs SYNGENE INTERNATIONAL LTD vs VA TECH WABAG LTD
SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs SYNGENE INTERNATIONAL LTD vs SAFARI INDUSTRIES (INDIA) LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z